prednisone has been researched along with sirolimus in 142 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (4.23) | 18.2507 |
| 2000's | 77 (54.23) | 29.6817 |
| 2010's | 51 (35.92) | 24.3611 |
| 2020's | 8 (5.63) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Almond, PS; Chen, S; Matas, A; Melin, M; Moss, A; Nakhleh, R; Salazar, A; Shirabe, K | 1 |
| Jordan, S; Kahan, BD; Murgia, MG | 1 |
| Kadin, ME; Nowak, I; Nowell, PC; Rook, AH; Shaw, LM; Vonderheid, EC; Wasik, MA; Zhang, Q | 1 |
| Kahan, BD; Zimmerman, JJ | 1 |
| Kahan, BD; Katz, SM; Meier-Kriesche, HU; Napoli, KL; Podbielski, J; Van Buren, CT | 1 |
| Appel-Dingemanse, S; Carter, C; Kahan, BD; Katz, SH; Van Buren, CT; Von Fellenberg, J; Wong, RL | 1 |
| Davis, DL; Gallant-Haidner, H; Kahan, BD; Murthy, JN; Napoli, KL; Soldin, SJ; Yatscoff, RW | 1 |
| Hong, JC; Kahan, BD | 1 |
| Belitsky, P; Kiberd, B; Lawen, J; MacDonald, A; Mahalati, K; McAlister, V; West, K | 1 |
| Coles, JG; Straatman, LP | 1 |
| Kahan, BD | 1 |
| Hong , JC; Kahan, BD | 1 |
| Hussein, I; Kahan, BD; Katz, S; Podbielski, J; Podder, H; Van Buren, C | 1 |
| Ettenger, RB; Grimm, EM | 1 |
| Budde, K; Figueiredo, J; Golor, G; Hartmann, S; Kovarik, JM; Lison, A; Neumayer, HH; Rordorf, C | 1 |
| Henriques, C; Mendes, AA; Oliveira, JG; Pestana, M; Sampaio, SM; Tavares, I; Xavier, P | 1 |
| Gonzalez-Posada, JM; Hdez-Marrero, D; Maceira, B; Pérez-Tamajón, L; Rodriguez, AP | 1 |
| Ducobu, J | 1 |
| Guilbeau, JM | 1 |
| Boger, R; Hoyer, PF; Kranz, B; Vester, U; Wehr, S | 1 |
| Kahan, BD; Langer, RM | 2 |
| Hong, DM; Katz, SM; Langer, RM; Van Buren, CT | 1 |
| Cahill, BC; Crompton, JA; Karwande, SV; O'Rourke, MK; Parker, ST; Somerville, KT; Stringham, JC | 1 |
| Carpenter, PA; Sanders, JE | 1 |
| Bäckman, L; Brattström, C; Calne, R; Campistol, JM; Charpentier, B; Claesson, K; Durand, D; Groth, CG; Kreis, H; Lang, P; Morales, JM; Touraine, JL; Wramner, L | 1 |
| Cosio, F; Gloor, J; Griffin, M; Ishitani, M; Kremers, W; Larson, TS; Lund, W; Nyberg, S; Prieto, M; Schwab, T; Stegall, MD; Sterioff, S; Textor, S; Velosa, J | 1 |
| Cowan, PA; Egidi, MF; Gaber, AO; Naseer, A | 1 |
| Abdel-Fattah, G; Kahan, BD; Morrisett, JD | 1 |
| Ahn, C; Hur, YG; Kang, MA; Lee, J; Won, J; Yun, SY | 1 |
| Goral, S; Helderman, JH; Kizilisik, AT; Langone, A; Nylander, WA; Shaffer, D | 1 |
| Gallay, BJ; Gandhi, MM; McVicar, JP; Perez, RV; Pierce, JL; Troppmann, C | 1 |
| Mohaupt, MG; Saner, E; Vogt, B | 1 |
| Baluarte, J; Brayman, KL; Harmon, WE; Meyers, KE; Palmer, JA; Salmanullah, M; Schachter, AD; Spaneas, LD | 1 |
| Alfieri, F; Felipe, CR; Franco, M; Garcia, R; Hanzawa, NM; Machado, PG; Medina-Pestana, JO; Park, SI; Silva, HT | 1 |
| Asolati, M; Dunn, D; Dunn, T; Gillingham, K; Gruessner, R; Harmon, J; Humar, A; Kandaswamy, R; Khwaja, K; Matas, AJ; Melancon, JK; Najarian, J; Payne, W; Sutherland, D | 1 |
| Alférez, MJ; Burgos, D; Cabello, M; González Molina, M; Gutiérrez de la Fuente, C; Navarro, A; Sola, E | 1 |
| Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA | 1 |
| Escuín, F; García de Miguel, A; Jiménez, C; Olea, T; Ros, S; Sanz, A | 1 |
| Alfieri, F; Casarini, D; Felipe, CR; Franco, M; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, S; Park, SI; Tedesco-Silva, H | 1 |
| Burke, JT; Cook, DJ; Flechner, SM; Hammond, JA; Head, SR; Kurian, SM; Lanigan, CM; Rollin, H; Salomon, DR; Solez, K; Whisenant, T | 1 |
| Derweesh, IH; Flechner, SM; Gill, I; Goel, MC; Goldfarb, DA; Modlin, CS; Mottoo, AM; Novick, AC; Streem, S | 1 |
| Blume, KG; Brown, J; Chao, NJ; Johnston, LJ; Negrin, RS; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ | 1 |
| Arbiser, JL; Nadiminti, U | 1 |
| Ader, JL; Allard, J; Durand, D; Kamar, N; Ribes, D; Rostaing, L | 1 |
| Alangaden, GJ; Chandrasekar, P; El-Amm, JM; Garnick, J; Granger, DK; Gruber, SA; Haririan, A; Morawski, K; Sillix, DH; West, MS | 1 |
| Barcenas, C; Benavides, C; Kahan, BD; Knight, R; Mahmoud, KH; Van Buren, CT | 1 |
| Banasik, M; Boratyńska, M; Klinger, M; Patrzalek, D; Szyber, P | 1 |
| Hymes, LC; Warshaw, BL | 1 |
| Alfieri, F; Casarini, DE; Felipe, CR; Ferreira, AN; Franco, M; Garcia, R; Hosaka, BH; Kamura, LA; Machado, PG; Medina-Pestana, JO; Motegi, SA; Park, SI; Tanaka, MK; Tedesco-Silva, H | 1 |
| Abdelnoor, A; Daouk, M; El-Hout, Y; Habbal, A; Houjaij, A; Hussein, M; Khauli, RB; Maacaron, H; Medawwar, W; Sawah, S; Uwaydah, M | 1 |
| De Meyer, M; Eddour, DC; Garrigue, V; Haufroid, V; Lison, D; Malaise, J; Mourad, G; Mourad, M; Squifflet, JP; Van Bellingen, C; Van Kerckhove, V; Wallemacq, P | 1 |
| Gautam, A; Gohh, R; Monaco, AP; Morrissey, PE; Yango, A | 1 |
| Khoury, N; Mougenot, B; Pellé, G; Rondeau, E; Xu, Y | 1 |
| Dickenmann, M; Kim, MJ; Mayr, M; Pechula, M; Steiger, J | 1 |
| Casarini, DE; Felipe, CR; Garcia, R; Machado, PG; Medina-Pestana, JO; Moreira, SR; Park, SI; Spinelli, GA; Tedesco-Silva, H | 1 |
| Buell, JF; Kahan, BD; Woodle, S; Yakupoglu, YK | 1 |
| Abecassis, M; Calmus, Y; Fischer, L; Freeman, R; Klempnauer, J; Langnas, A; Levy, G; Mayer, D; Nashan, B; Neuhaus, P; Punch, J; Roberts, J; Rogiers, X; Samuel, D; Schmidli, H; Sloof, M; Tuttle-Newhall, E | 1 |
| Maheshwari, A; Thuluvath, PJ; Torbenson, MS | 1 |
| Feurer, I; Helderman, JH; Kizilisik, AT; Langone, AJ; Nylander, WA; Schaefer, HM; Shaffer, D | 1 |
| Rana, JS; Sheikh, J | 1 |
| Biancone, L; Gai, M; Giraudi, R; Leonardi, G; Magnano, A; Messina, M; Piccoli, GB; Rossetti, M; Segoloni, GP | 1 |
| Campistol, JM; Cofán, F; Diekmann, F; Esforzado, N; Gutiérrez-Dalmau, A; López, S; Oppenheimer, F; Ricart, MJ; Rossich, E; Saval, N; Torregrosa, JV | 1 |
| Bonapace, L; Bornhauser, BC; Bourquin, JP; Cario, G; Lindholm, D; Martinez, R; Niggli, FK; Schäfer, BW; Schrappe, M | 1 |
| Bennett, K; McCalmont, V | 1 |
| Járay, J; Kahan, BD; Langer, R; Máthé, Z; Remport, A; Tóth, A | 1 |
| Arellano, EM; Campistol, JM; Cofán, F; Crespo, M; Diekmann, F; Esforzado, N; Gutiérrez-Dalmau, A; Oppenheimer, F; Ricart, MJ; Rossich, E; Saval, N; Torregrosa, JV | 1 |
| Altieri, P; Carmellini, M; Corbetta, G; Cossu, M; Iorio, B; Montagnino, G; Ponticelli, C; Rigotti, P; Salvadori, M; Sandrini, S; Schena, FP; Stefoni, S | 1 |
| Harold, K; Mekeel, K; Moss, A; Mulligan, D; Reddy, KS | 1 |
| Daloze, P; Demirbas, A; Ekberg, H; Frei, U; Grinyó, JM; Gürkan, A; Halloran, PF; Hugo, C; Margreiter, R; Nashan, B; Tedesco-Silva, H; Vanrenterghem, Y; Vítko, S | 1 |
| Rosen, T; Snavely, NR; Sonabend, M | 1 |
| Guba, M; Jauch, KW | 1 |
| Kim, MK; Ko, JH; Lee, HJ; Lee, JH; Lee, JL; Min, BM; Oh, JY; Shin, YJ; Sohn, YS; Wee, WR | 1 |
| Braylan, RC; Dharnidharka, VR; Henry, DD; Hunger, SP | 1 |
| Conti, DJ; Elbalhoul, O; Gallichio, M; Petrov, R | 1 |
| Ogura, M | 1 |
| Stevens, RB | 1 |
| Baker, PB; Hayes, JR; Iorember, FM; Mahan, JD; Ohana, A; Patel, HP; Rajab, A | 1 |
| Casarini, DE; Felipe, CR; Fernandes, FB; Garcia, R; Medina-Pestana, JO; Park, SI; Pinheiro-Machado, PG; Tedesco-Silva, H | 1 |
| Aires, I; Carvalho, D; Ferreira, A; Nolasco, F; Pinto, JR; Possante, M; Remédio, F; Santos, JR | 1 |
| Bandin, F; Baudouin, V; Carol, A; Cassaing, S; Decramer, S; Garnier, A; Guigonis, V; Kwon, T; Linas, MD; Valentin, A | 1 |
| Delgado, DH; Gustafsson, F; Rao, V; Ross, HJ; Sheedy, J; Sheshgiri, R | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Bookout, R; Fernandez, HF; Field, T; Greene, J; Hoda, D; Janssen, W; Kharfan-Dabaja, MA; Kim, J; Ochoa-Bayona, JL; Perez, L; Perkins, J; Pidala, J; Raychaudhuri, J; Salgado-Vila, N | 1 |
| El-Embaby, A; Grawish, Mel-A; Karrouf, GI; Mahmoud, SH; Sobh, MA; Zaher, AR | 1 |
| Dinits-Pensy, M; Drachenberg, CB; Haririan, A; Klassen, DK; Munivenkatappa, R; Papadimitriou, JC | 1 |
| Gaber, AO; Kahan, BD; Katz, SM; Kerman, RH; Knight, RJ; Lawless, A; Podder, H; Van Buren, CT | 1 |
| Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT | 1 |
| Alfieri, F; de Sandes Freitas, TV; Felipe, CR; Galante, NZ; Harada, KM; Ikehara, E; Medina-Pestana, JO; Sampaio, EL; Tedesco-Silva Júnior, H | 1 |
| Felipe, CR; Mandia-Sampaio, EL; Medina-Pestana, JO; Park, SI; Spinelli, GA; Tedesco-Silva, H | 1 |
| Chhabra, D; Dalal, P; Gallon, L; Leventhal, JR; Shah, G; Skaro, AI; Wang, E | 1 |
| Alonso, EM; Ekong, UD; Mathew, J; Melin-Aldana, H; Wang, D | 1 |
| Cavanaugh, TM; Goebel, J; Schoenemen, H | 1 |
| Bruno, F; Gesualdo, L; Grandaliano, G; Infante, B; Stallone, G; Tartaglia, L | 1 |
| Felipe, CR; Medina Pestana, JO; Schmouder, RL; Slade, A; Tedesco-Silva, H | 1 |
| Wagner, JA | 1 |
| Cardona, M; Castel, MÁ; Farrero, M; Pérez-Villa, F | 1 |
| Chinnakotla, S; Dunn, TB; Finger, EB; Gillingham, KJ; Kandaswamy, R; Matas, AJ; Najarian, JS; Payne, WD; Pruett, TL; Rizzari, MD; Suszynski, TM; Sutherland, DER | 1 |
| Boccuzzi, G; De Luca, G; Ferrero, V; Ghini, AS; Marino, P; Pesarini, G; Presbitero, P; Ribichini, F; Rognoni, A; Tomai, F; Vassanelli, C; Zivelonghi, C | 1 |
| Faria, E; Matin, SF; Rao, P; Turturro, F | 1 |
| Eom, HS; Huh, J; Kang, HJ; Kim, JS; Kim, SJ; Kim, WS; Ko, YH; Lee, J; Lee, SS; Lee, SY; Park, WS; Suh, C; Yang, WI; Yim, DS | 1 |
| Alvarado, A; Chhabra, D; Dalal, P; Gallon, L; Leventhal, J; Levitsky, J; Mas, V; Najafian, N; Skaro, A; Sustento-Reodica, N; Wang, C | 1 |
| Ayli, MD; Demir, ME; Ercan, Z; Merhametsiz, O; Ulas, T; Yayar, O | 1 |
| Contieri, FL; de Carvalho, DD; Felipe, CR; Filho, MA; Garcia, VD; Neto, ED; Pestana, JO; Silva, HT | 1 |
| Bai, X; Cao, L; Dai, L; Li, J; Ruan, C; Su, J; Wang, Z; Yu, Z; Zhu, M | 1 |
| Chalkias, S; Dooley, C; Gay, C; Li, T; Mackenzie, MR; Marty, FM; Moss, RB; Routh, RL; Tan, CS; Walsh, SR | 1 |
| Dahllöf, G; Heimdahl, A; Legert, KG; Remberger, M; Ringdén, O | 1 |
| Belingheri, M; Cardillo, M; Dello Strologo, L; Ferraresso, M; Ghio, L; Ghirardo, G; Ginevri, F; Guzzo, I; Innocente, A; Murer, L; Parodi, A | 1 |
| Allen, L; Boyer, TD; Chatrath, H | 1 |
| Baranowska-Bosiacka, I; Bober, J; Ciechanowski, K; Domański, L; Domański, M; Kabat-Koperska, J; Kedzierska, K; Kolasa, A; Osekowska, B; Parafiniuk, M; Safranow, K; Sindrewicz, K; Smektała, T; Sporniak-Tutak, K; Urasińska, E | 1 |
| Fishman, PM; Kadkol, SS; Krunic, AL; Nuovo, GJ; Vance, KK | 1 |
| Hata, T; Lee, RA; Li, C; Wu, W | 1 |
| Citterio, F; Favi, E; Pedroso, JA; Romagnoli, J; Salerno, MP; Spagnoletti, G | 1 |
| Chapman, JR; Craig, JC; Henderson, L; Masson, P; Webster, AC | 1 |
| Antoniucci, D; Cassese, S; Cernigliaro, C; De Luca, G; Fernandez-Pereira, C; Kastrati, A; Proietti, I; Ribichini, F; Rodriguez, AE; Sansa, M; Serruys, PW; Stankovic, G; Stojkovic, S; Tomai, F; Vassanelli, C; Versaci, F | 1 |
| Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J | 1 |
| Aguiar, W; Campos, E; Cristelli, M; Felipe, C; Ferreira, A; Franco, M; Gerbase-DeLima, M; Medina-Pestana, J; Oliveira, N; Sandes-Freitas, T; Tedesco-Silva, H | 1 |
| Alberici, F; Baldari, G; Becchi, G; Buzio, C; Corradi, D; De Filippo, M; Di Gangi, M; Emile, JF; Ferretti, S; Foti, R; Galetti, M; Gianfreda, D; Jeannin, G; Moroni, G; Nicastro, M; Saffroy, R; Vaglio, A | 1 |
| Aleksiejuk, P; Banki, K; Bonilla, E; Francis, L; Landas, SK; Liu, Y; Marchena-Mendez, I; Oaks, Z; Patel, J; Perl, A; Yu, J | 1 |
| Amoura, Z; Haroche, J | 1 |
| Felipe, CR; Felix, MJ; Osmar Medina-Pestana, J; Tedesco-Silva, H | 1 |
| Camarena-Arias, PA; García-Bello, JA; Mendoza-Gómez, E; Romo-Del Río, EG; Santos-Caballero, M | 1 |
| Chen, G; Ding, T; Lin, ZB; Wang, XX; Zhu, L | 1 |
| Santamarina, M; Vega, J | 1 |
| Mashabane, MJ; Motse, KG | 1 |
| Bohacova, P; Hajkova, M; Hermankova, B; Holan, V; Javorkova, E; Krulova, M; Zajicova, A | 1 |
| Barratt, J; Kim, MJ; Koller, MT; Molyneux, K; Schaub, S; Stampf, S | 1 |
| Alvarez-Elías, AC; Filler, G; Singh, RN; Todorova, EK; Yoo, EC | 1 |
| Arai, S; Arora, M; Carpenter, PA; Cutler, CS; Flowers, MED; Inamoto, Y; Jagasia, M; Lee, SJ; Martin, PJ; Palmer, J; Pidala, J; Storer, BE | 1 |
| Jang, S; Sadaat, M | 1 |
| Karolak, W; Ochman, M; Wojarski, J; Żegleń, S | 1 |
| Alousi, AM; Anasetti, C; Antin, JH; Bolaños-Meade, J; Chhabra, S; Dawson, P; Efebera, YA; Ferrara, JLM; Hamadani, M; Holtan, SG; Horowitz, MM; Howard, A; Jagasia, M; Leifer, ES; Levine, JE; Logan, BR; MacMillan, ML; Martens, M; Mielcarek, M; Pidala, J; Pritchard, TS; Pusic, I | 1 |
| Bouabdallah, K; Burroni, B; Cartron, G; Casasnovas, O; Gressin, R; Gyan, E; Haioun, C; Hermine, O; Joubert, C; Lamy, T; Le Gouill, S; Sarkozy, C; Tessoulin, B; Thieblemont, C | 1 |
| Li, M; Wang, Q; Wu, C; Xu, D; Zeng, X | 1 |
| Gill, K; Grabowska, M; Kędzierska-Kapuza, K; Kram, A; Michałek, K; Piasecka, M | 1 |
| Ferreira, V; Hall, VG; Humar, A; Kumar, D | 1 |
| Cao, Y; Chen, J; Guan, X; Hu, Q; Huang, X; Jiang, J; Li, X; Liu, H; Wu, W; Yin, S; Yuan, S; Zhou, J; Zhou, Y | 1 |
| Bai, YJ; Chen, XM; Li, H; Shi, YY; Wang, LL; Wu, Y | 1 |
| Gao, H; Liu, S; Luo, C; Mai, Y; Pan, C; Wang, Y; Zhang, X; Zheng, S | 1 |
8 review(s) available for prednisone and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.
Topics: Adolescent; Age Factors; Azathioprine; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Everolimus; Graft Rejection; Graft Survival; Half-Life; Humans; Immunosuppressive Agents; Intestinal Absorption; Kidney Transplantation; Prednisone; Sirolimus; Treatment Outcome | 2001 |
[Metabolic modifications related to immunosuppressive drugs].
Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Lung Transplantation; Mycophenolic Acid; Prednisone; Prognosis; Sirolimus; Tacrolimus; Transplantation Immunology | 2002 |
Steroid-refractory graft-vs.-host disease: past, present and future.
Topics: Acute Disease; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Chronic Disease; Cyclosporine; Daclizumab; Glucocorticoids; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Mycophenolic Acid; Photopheresis; Prednisone; Prodrugs; Sirolimus; Tacrolimus | 2003 |
Progressive multifocal leukoencephalopathy: a case study.
Topics: Aged; Biopsy; Confusion; Early Diagnosis; Electroencephalography; Fatal Outcome; Hallucinations; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Polymerase Chain Reaction; Prednisone; Rare Diseases; Sirolimus; Spinal Puncture | 2007 |
[Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Gene Targeting; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Nitrogen Mustard Compounds; Prednisone; Prognosis; Purine Nucleosides; Pyrimidinones; Risk; Rituximab; Salvage Therapy; Sirolimus; Transplantation, Autologous; Vincristine | 2008 |
Belatacept for kidney transplant recipients.
Topics: Abatacept; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2014 |
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials.
Topics: Administration, Oral; Aged; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Percutaneous Coronary Intervention; Prednisone; Proportional Hazards Models; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome | 2014 |
45 trial(s) available for prednisone and sirolimus
| Article | Year |
|---|---|
The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.
Topics: Adult; Anti-Inflammatory Agents; Blood Pressure; Cyclosporine; Double-Blind Method; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Liver Function Tests; Male; Platelet Count; Polyenes; Prednisone; Sirolimus | 1996 |
Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration.
Topics: Administration, Oral; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polyenes; Prednisone; Sirolimus | 1997 |
Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.
Topics: Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Sirolimus | 1998 |
A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients.
Topics: Adult; Aged; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Everolimus; Female; Glucocorticoids; Half-Life; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Retreatment; Sirolimus | 1999 |
Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management.
Topics: Adolescent; Adult; Aged; Cadaver; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukopenia; Living Donors; Male; Middle Aged; Postoperative Complications; Prednisone; Sirolimus; Thrombocytopenia; Tissue Donors | 2000 |
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Biopsy; Cyclosporine; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2000 |
Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cyclosporine; Dietary Fats; Drug Interactions; Everolimus; Fasting; Half-Life; Headache; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Prednisone; Sirolimus; Time Factors | 2002 |
Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation.
Topics: Adult; Biopsy, Needle; Cyclosporine; Cytokines; Drug Therapy, Combination; Graft Rejection; Growth Substances; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Monocytes; Mycophenolic Acid; Postoperative Period; Prednisone; Receptors, Growth Factor; Sirolimus | 2002 |
Immunosuppression with sirolimus, cyclosporyne, and prednisone in renal transplantation.
Topics: Anticholesteremic Agents; Bacterial Infections; Cholesterol; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Patient Selection; Postoperative Complications; Prednisone; Sirolimus; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Triglycerides | 2002 |
Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: interim analysis after 3 months.
Topics: Adolescent; Child; Cyclosporine; Drug Therapy, Combination; Ethnicity; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Sirolimus; Time Factors | 2002 |
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Drug Therapy, Combination; France; Graft Rejection; Hospitals, University; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Prednisolone; Prednisone; Sirolimus | 2003 |
Kidney transplantation without calcineurin inhibitors using sirolimus.
Topics: Calcineurin Inhibitors; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Prednisone; Sirolimus; Time Factors; Transplantation, Homologous | 2003 |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Matched-Pair Analysis; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Sirolimus; Surgical Wound Infection; Survival Rate; Tacrolimus; Treatment Outcome | 2003 |
An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Prednisone; Prospective Studies; Safety; Sirolimus | 2004 |
Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Treatment Outcome | 2004 |
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.
Topics: Adult; Aged; Biopsy; Calcineurin Inhibitors; Cyclosporine; Graft Survival; Humans; Immunosuppressive Agents; Inflammation; Kidney Function Tests; Kidney Transplantation; Middle Aged; Oligonucleotide Array Sequence Analysis; Prednisone; Sirolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2004 |
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Topics: Adult; Calcineurin Inhibitors; Cause of Death; Chronic Disease; Creatinine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Patient Compliance; Prednisone; Recurrence; Sirolimus; Treatment Outcome | 2005 |
Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Prednisone; Sirolimus; Time Factors | 2005 |
Concentration-controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12-month results.
Topics: Adult; Biopsy; Black or African American; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisone; Prospective Studies; Sirolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus | 2005 |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Genotype; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polymorphism, Genetic; Prednisone; Sirolimus; Steroids; Tacrolimus | 2005 |
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Topics: Adult; Cholesterol; Cholesterol, LDL; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Kidney; Leukopenia; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Prednisone; Sirolimus; Thrombocytopenia; Treatment Outcome; Triglycerides | 2006 |
Short-term results under three different immunosuppressive regimens at one center.
Topics: Adrenal Cortex Hormones; Biopsy; Creatinine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Methylprednisolone; Mycophenolic Acid; Prednisone; Sirolimus; Survival Analysis; Treatment Outcome | 2006 |
Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
Topics: Aged; Calcineurin Inhibitors; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Prednisone; Protein Kinases; Proteinuria; Sirolimus; Time Factors; TOR Serine-Threonine Kinases | 2007 |
Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Recombinant Fusion Proteins; Renal Insufficiency; Risk Factors; Sirolimus | 2007 |
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.
Topics: Adult; Cyclosporine; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus | 2008 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Cyclosporine; Daclizumab; Diabetes Mellitus; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Prednisone; Sirolimus; Tacrolimus; Treatment Failure | 2007 |
Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus; Tacrolimus; Time Factors; Tissue Distribution | 2009 |
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus; Venous Thromboembolism | 2011 |
Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Biopsy; Calcineurin Inhibitors; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prednisone; Sirolimus; Tacrolimus; Young Adult | 2011 |
Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Topics: Acute Disease; Adult; Biopsy; Chi-Square Distribution; Chicago; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Topics: Adrenal Cortex Hormones; Adult; Biotransformation; Circadian Rhythm; Cross-Over Studies; Cyclosporine; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Everolimus; Female; Glucuronides; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prodrugs; Sirolimus; Tablets, Enteric-Coated | 2012 |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.
Topics: Adult; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2013 |
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Re
Topics: Administration, Oral; Anti-Inflammatory Agents; Coronary Restenosis; Cortisone; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prednisone; Sirolimus; Treatment Outcome; Tubulin Modulators | 2013 |
A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Everolimus; Humans; Lymphoma, T-Cell, Peripheral; Maximum Tolerated Dose; Prednisone; Sirolimus; Vincristine | 2013 |
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.
Topics: Adult; Allografts; Anti-Inflammatory Agents; Calcineurin Inhibitors; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Prognosis; Prospective Studies; Sirolimus; Survival Rate; Tacrolimus; TOR Serine-Threonine Kinases | 2013 |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients.
Topics: Adult; Biopsy; Creatinine; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Renal Insufficiency; Sirolimus; Tacrolimus; Treatment Outcome | 2013 |
Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cytokines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Sirolimus; T-Lymphocytes, Regulatory; Treatment Outcome; Young Adult | 2013 |
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Prospective Studies; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Treatment Outcome | 2015 |
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial.
Topics: Adult; Aged; Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Sirolimus; Treatment Outcome | 2015 |
Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Topics: Adult; Brazil; Calcineurin Inhibitors; Drug Eruptions; Drug Monitoring; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Severity of Illness Index; Sirolimus; Subcutaneous Tissue; Tacrolimus; TOR Serine-Threonine Kinases | 2016 |
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Topics: Adult; Aged; Calcineurin Inhibitors; Chronic Disease; Disease Progression; Endpoint Determination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Photopheresis; Prednisone; Prospective Studies; Recurrence; Rituximab; Severity of Illness Index; Sirolimus; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; United States | 2017 |
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Bone Marrow Transplantation; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Prednisone; Prognosis; Sirolimus; Survival Rate; Young Adult | 2020 |
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Immunotherapy; Lymphoma, Mantle-Cell; Male; Middle Aged; Prednisone; Rituximab; Sirolimus; Survival Rate; Thrombocytopenia; Vincristine | 2020 |
Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Connective Tissue Diseases; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Sirolimus; Sjogren's Syndrome; Thrombocytopenia; Time Factors; Young Adult | 2021 |
89 other study(ies) available for prednisone and sirolimus
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rapamycin in a porcine renal transplant model.
Topics: Animals; Azathioprine; Biopsy; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Kidney Transplantation; Polyenes; Prednisone; Sirolimus; Swine; Transplantation, Homologous | 1993 |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Topics: Cell Membrane; Cyclosporine; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Janus Kinase 3; Lymphocyte Activation; Lymphoma, T-Cell, Cutaneous; Milk Proteins; Phosphorylation; Polyenes; Prednisone; Protein Binding; Protein-Tyrosine Kinases; Receptors, Interleukin-2; Sezary Syndrome; Signal Transduction; Sirolimus; STAT3 Transcription Factor; STAT5 Transcription Factor; Tacrolimus; Trans-Activators; Tumor Cells, Cultured | 1996 |
Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay.
Topics: Animals; Binding, Competitive; Cattle; Chromatography, High Pressure Liquid; Cross Reactions; Cyclosporine; Immunophilins; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Culture Test, Mixed; Prednisone; Protein Binding; Radioligand Assay; Sirolimus; Thrombocytopenia | 2000 |
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Period; Predictive Value of Tests; Prednisone; Sirolimus; Time Factors | 2000 |
Pediatric utilization of rapamycin for severe cardiac allograft rejection.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Platelet Count; Prednisone; Rabbits; Safety; Sirolimus; T-Lymphocytes; Tacrolimus | 2000 |
Sirolimus rescue therapy for refractory rejection in renal transplantation.
Topics: Adult; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Osmolar Concentration; Prednisone; Salvage Therapy; Sirolimus; Treatment Outcome | 2001 |
Sirolimus improves the two-year outcome of renal allografts in African-American patients.
Topics: Acute Disease; Adult; Black or African American; Black People; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Time Factors; Treatment Outcome; White People | 2001 |
Delayed wound healing with sirolimus after liver transplant.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pneumonia, Pneumocystis; Prednisone; Reoperation; Sirolimus; Surgical Wound Dehiscence; Tacrolimus | 2002 |
Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Prednisone; Retrospective Studies; Sirolimus | 2002 |
Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors.
Topics: Adult; Antibodies, Monoclonal; Basiliximab; Cholesterol; Creatinine; Cyclosporine; Drug Therapy, Combination; Ethnicity; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Sirolimus; Texas | 2002 |
Early experience with sirolimus in lung transplant recipients with chronic allograft rejection.
Topics: Bronchiolitis Obliterans; Calcineurin Inhibitors; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Spirometry; Transplantation, Homologous | 2003 |
Conversion to sirolimus in solid organ transplantation: a single-center experience.
Topics: Adult; Calcineurin Inhibitors; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Pancreas Transplantation; Postoperative Complications; Prednisone; Racial Groups; Retrospective Studies; Sirolimus; Time Factors | 2003 |
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
Topics: Adult; Cadaver; Cholesterol; Cyclosporine; Female; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoproteins; Living Donors; Male; Middle Aged; Prednisone; Sirolimus; Tissue Donors; Transplantation, Homologous; Triglycerides | 2003 |
Synergistic immunosuppressive effects of rosmarinic acid and rapamycin in vitro and in vivo.
Topics: Animals; Cell Division; Cinnamates; Cyclosporine; Depsides; Drug Synergism; Glucocorticoids; Graft Survival; Immunosuppressive Agents; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Prednisone; Rosmarinic Acid; Sirolimus; Skin Transplantation; Spleen; T-Lymphocytes | 2003 |
A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function.
Topics: Adult; Aged; Calcineurin Inhibitors; Clinical Protocols; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Mycophenolic Acid; Pilot Projects; Prednisone; Recovery of Function; Sirolimus; Tacrolimus | 2003 |
Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Lymphocele; Male; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies; Risk Factors; Sirolimus; Thromboembolism | 2003 |
[Irritant cough and sub-febrile temperature under immunosuppression].
Topics: Anti-Inflammatory Agents; Body Temperature; Bronchoalveolar Lavage Fluid; Bronchoscopy; Coronary Artery Bypass; Cough; Cyclosporine; Diabetic Nephropathies; Diagnosis, Differential; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Middle Aged; Prednisone; Radiography, Thoracic; Risk Factors; Sirolimus; Tomography, X-Ray Computed; Xenobiotics | 2004 |
Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Area Under Curve; Child; Child, Preschool; Daclizumab; Drug Monitoring; Female; Follow-Up Studies; Graft Rejection; Half-Life; Humans; Immunoglobulin G; Immunosuppressive Agents; IMP Dehydrogenase; Infant; Kidney Transplantation; Male; Mycophenolic Acid; Neutropenia; Prednisone; Receptors, Interleukin-2; Sirolimus | 2004 |
Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients.
Topics: Antilymphocyte Serum; Case-Control Studies; Creatinine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Necrosis; Prednisone; Sirolimus; Time Factors | 2004 |
[De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
Topics: Adult; Antibodies, Monoclonal; Basiliximab; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Duodenostomy; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Jejunostomy; Kidney Failure, Chronic; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Mycophenolic Acid; Pancreas Transplantation; Pancreatic Fistula; Plasma; Postoperative Complications; Prednisone; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2004 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosin; Drug Therapy, Combination; Famotidine; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Interstitial; Male; Muscular Diseases; Mycophenolic Acid; Pneumonia, Bacterial; Postoperative Complications; Prednisone; Sirolimus | 2004 |
[Calcineurin-inhibitor-free immunosuppression in early renal transplantation].
Topics: Adult; Calcineurin Inhibitors; Comorbidity; Cyclosporine; Drug Therapy, Combination; Fever; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Pyelonephritis; Recurrence; Sirolimus; Ureteral Diseases; Urinary Bladder Fistula; Urinary Fistula | 2004 |
Fate of donor kidney: laparoscopic versus open technique.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Laparoscopy; Male; Mycophenolic Acid; Nephrectomy; Prednisone; Retrospective Studies; Sirolimus; Tacrolimus; Time Factors; Tissue Donors | 2004 |
Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis.
Topics: Adult; Autoimmune Diseases; Dermatomyositis; Female; Glucocorticoids; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Prednisone; Sirolimus | 2005 |
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, Viral; Antilymphocyte Serum; Antiviral Agents; Basiliximab; Black or African American; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Phosphoproteins; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Risk Assessment; Serologic Tests; Sirolimus; Tacrolimus; Valganciclovir; Viral Matrix Proteins | 2005 |
Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?
Topics: Adult; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Body Mass Index; Cohort Studies; Creatinine; Cyclosporine; Drug Therapy, Combination; Ethnicity; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Rabbits; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Sirolimus | 2005 |
Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
Topics: Adult; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Tissue Donors; Treatment Failure; Wound Healing | 2005 |
Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.
Topics: Child; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Prednisone; Sirolimus; Tacrolimus; Treatment Outcome | 2005 |
Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.
Topics: Creatinine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Retrospective Studies; Sirolimus | 2005 |
Thrombotic microangiopathy in marginal kidneys after sirolimus use.
Topics: Aged; Arterioles; Biopsy; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrin; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Microcirculation; Middle Aged; Mycophenolic Acid; Organ Preservation; Prednisone; Sirolimus; Thrombosis; Tissue and Organ Harvesting; Transplants | 2005 |
Marked erythrocyte microcytosis under primary immunosuppression with sirolimus.
Topics: Adult; Aged; Cyclosporine; Erythrocytes, Abnormal; Female; Hemoglobins; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Sirolimus | 2006 |
Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipid Metabolism; Male; Prednisone; Severity of Illness Index; Sirolimus; Time Factors | 2006 |
Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy.
Topics: Databases, Factual; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Neoplasms; Prednisone; Registries; Sirolimus; Treatment Outcome | 2006 |
Sirolimus monotherapy versus sirolimus in combination with steroids and/or MMF for immunosuppression after liver transplantation.
Topics: Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Sirolimus | 2006 |
Serum sickness-like reactions after placement of sirolimus-eluting stents.
Topics: Aged; Anti-Inflammatory Agents; Arthralgia; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prednisone; Serum Sickness; Sirolimus; Stents; Urticaria | 2007 |
No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report.
Topics: Adult; Female; Glomerulonephritis; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Reoperation; Sarcoma, Kaposi; Secondary Prevention; Sirolimus | 2007 |
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotting, Western; Caspases; Cell Line, Tumor; Cell Survival; Dexamethasone; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Humans; Neoplasm, Residual; Oxides; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Remission Induction; RNA, Small Interfering; Signal Transduction; Sirolimus; Transfection; X-Linked Inhibitor of Apoptosis Protein | 2007 |
[Lymphocele and kidney transplantation].
Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Sirolimus | 2007 |
Laparoscopic incisional hernia repair after liver transplantation.
Topics: Aged; Female; Graft Rejection; Hernia, Ventral; Humans; Immunosuppressive Agents; Laparoscopy; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Recurrence; Retrospective Studies; Sirolimus; Surgical Mesh; Surgical Wound Infection; Tacrolimus | 2007 |
Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.
Topics: Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Face; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Prednisone; Pulmonary Fibrosis; Sirolimus; Skin Diseases | 2007 |
Reduced exposure to calcineurin inhibitors in renal transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcineurin Inhibitors; Daclizumab; Drug Therapy, Combination; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisone; Protein Kinases; Sirolimus; Tacrolimus; Therapeutic Equivalency; TOR Serine-Threonine Kinases | 2008 |
Short-term Efficacy of Topical Immunosuppressive Agents on the Survival of Cultivated Allo-Conjunctival Equivalents.
Topics: Administration, Topical; Animals; Cell Count; Cell Transplantation; Cells, Cultured; Conjunctiva; Cyclosporine; Epithelial Cells; Female; Fluorescent Antibody Technique, Indirect; Graft Survival; Immunosuppressive Agents; Keratin-4; Keratin-7; Male; Organic Chemicals; Prednisone; Rabbits; Sirolimus; Transplantation, Homologous | 2008 |
Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Topics: Abscess; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cecum; Child; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Prednisone; Rituximab; Sirolimus; Tongue Neoplasms; Viral Load | 2008 |
Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.
Topics: Adult; Aged; Calcineurin Inhibitors; Creatinine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Tacrolimus | 2008 |
Modern approaches to combining sirolimus with calcineurin inhibitors.
Topics: Adrenal Cortex Hormones; Animals; Antilymphocyte Serum; Calcineurin Inhibitors; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone; Probability; Rabbits; Sirolimus; Survival Analysis; Survivors; Transplantation, Homologous | 2008 |
Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis.
Topics: Adolescent; Biopsy; Contraindications; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Morbidity; Prednisone; Retrospective Studies; Sirolimus; Time Factors; Treatment Outcome; United States | 2010 |
Sirolimus-induced drug fever in a renal transplant patient: a case report.
Topics: Fever; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Radiography, Thoracic; Sirolimus; Treatment Outcome | 2009 |
Cryptosporidiosis in paediatric renal transplantation.
Topics: Adolescent; Antiparasitic Agents; Biopsy; Child; Cohort Studies; Cryptosporidiosis; Diarrhea; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Nitro Compounds; Prednisone; Sirolimus; Tacrolimus; Thiazoles; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.
Topics: Adult; Aged; Area Under Curve; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Heart Transplantation; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Humans; Immunosuppressive Agents; Male; Maternal-Fetal Exchange; Middle Aged; Mycophenolic Acid; Prednisone; Pregnancy; Pregnancy Proteins; Sirolimus | 2009 |
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease.
Topics: Acute Disease; Adult; Aged; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Prednisone; Retrospective Studies; Sirolimus; Steroids; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Influence of selective immunosuppressive drugs on the healing of exposed dogs' dental pulp capped with mineral trioxide aggregate.
Topics: Aluminum Compounds; Animals; Calcium Compounds; Cyclosporine; Dental Pulp; Dental Pulp Capping; Dental Pulp Exposure; Dentin, Secondary; Dogs; Drug Combinations; Immunosuppressive Agents; Male; Mycophenolic Acid; Necrosis; Oxides; Prednisone; Pulpitis; Silicates; Sirolimus; Wound Healing | 2010 |
Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF.
Topics: Adult; Apoptosis; Biopsy; Caspase 3; Delayed Graft Function; Drug Therapy, Combination; Epithelial Cells; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Mycophenolic Acid; Podocytes; Prednisone; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Sirolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous; Treatment Outcome | 2010 |
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisone; Sirolimus; Time Factors; Treatment Outcome | 2010 |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.
Topics: Adult; Analysis of Variance; Biomarkers; Brazil; Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Dyslipidemias; Everolimus; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipids; Logistic Models; Male; Middle Aged; Mycophenolic Acid; Odds Ratio; Prednisone; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2011 |
Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
Topics: Azathioprine; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant; Liver; Liver Transplantation; Male; Postoperative Complications; Prednisone; Retrospective Studies; Single-Blind Method; Sirolimus; T-Lymphocytes, Regulatory; Tacrolimus; Treatment Outcome | 2012 |
The impact of sirolimus on sex hormones in male adolescent kidney recipients.
Topics: Adolescent; Child; Follicle Stimulating Hormone; Glomerular Filtration Rate; Gonadal Steroid Hormones; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Prednisone; Regression Analysis; Retrospective Studies; Sirolimus; Testosterone | 2012 |
Renal angiomyolipomatosis and Kaposi's sarcoma: a possible link disrupted by sirolimus.
Topics: Aged; Angiomyolipoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Nephrectomy; Prednisone; Sarcoma, Kaposi; Sirolimus; Splenectomy; Tomography, X-Ray Computed; Vincristine | 2012 |
Cancer after heart transplant: implications for practice.
Topics: Azathioprine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisone; Sirolimus; Skin Neoplasms; Tacrolimus | 2012 |
[Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience].
Topics: Antibodies, Monoclonal; Basiliximab; Calcineurin Inhibitors; Creatinine; Drug Therapy, Combination; Everolimus; Follow-Up Studies; Graft Rejection; Heart Transplantation; Herpes Zoster; Humans; Immunosuppressive Agents; Kidney Diseases; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Sirolimus; Stomatitis, Herpetic; Tacrolimus; Virus Activation | 2013 |
Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.
Topics: Angiomyolipoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Everolimus; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Radiography; Sirolimus; Vincristine | 2013 |
Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Delayed Diagnosis; Dermatitis; Diagnostic Errors; Drug Substitution; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Postoperative Period; Prednisone; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Tacrolimus; Vinblastine | 2013 |
DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation.
Topics: Aged; Antiviral Agents; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Paramyxoviridae Infections; Pneumonia, Viral; Prednisone; Recombinant Fusion Proteins; Respiration, Artificial; Respiratory Insufficiency; Sirolimus; Treatment Outcome | 2014 |
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multivariate Analysis; Oral Hygiene; Prednisone; Sirolimus; Stomatitis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult | 2014 |
Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.
Topics: Adolescent; Antibodies, Monoclonal; Basiliximab; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Prospective Studies; Recombinant Fusion Proteins; Sirolimus; Treatment Outcome | 2014 |
Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Drug Resistance; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prednisone; Sirolimus; Young Adult | 2014 |
The effect of immunosuppressive therapy on renal cell apoptosis in native rat kidneys.
Topics: Animals; Apoptosis; Cyclosporine; Immunosuppressive Agents; Kidney; Male; Mycophenolic Acid; Prednisone; Rats; Rats, Wistar; Sirolimus; Tacrolimus | 2015 |
Dramatic regression of recalcitrant human papillomavirus type 1-related palmar verrucae and squamous cell carcinoma in situ following R-CHOP chemotherapy and transition to sirolimus in a renal transplant patient with diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasms, Multiple Primary; Postoperative Complications; Prednisone; Remission Induction; Rituximab; Sirolimus; Skin Diseases; Skin Neoplasms; Vincristine; Warts | 2015 |
The use of sirolimus to treat Kaposi's sarcoma in an HIV-negative rheumatoid arthritis patient on disease-modifying drug therapies.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Arthritis, Rheumatoid; HIV Seronegativity; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms | 2015 |
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intestinal Obstruction; Kidney Transplantation; Peritoneal Dialysis; Peritoneal Fibrosis; Prednisone; Sirolimus | 2014 |
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases | 2015 |
Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Antibodies, Antinuclear; Aspartate Aminotransferases; Azathioprine; Biomarkers; Cohort Studies; Complement System Proteins; Cyclosporine; Diabetes Mellitus; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Liver Diseases; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prevalence; Retrospective Studies; Severity of Illness Index; Sex Distribution; Sirolimus | 2015 |
mTOR: a new target in Erdheim-Chester disease?
Topics: Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Sirolimus | 2015 |
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study.
Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Cyclosporine; Female; Humans; Hypertension; Hypertriglyceridemia; Hyperuricemia; Immunosuppressive Agents; Immunotherapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Prevalence; Retrospective Studies; Risk Factors; Sirolimus; Tacrolimus; Young Adult | 2016 |
[Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Topics: Adult; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Prospective Studies; Proteinuria; Sirolimus; Transplantation, Homologous | 2016 |
[Sirolimus and prednisone for the treatment of Erdheim-Chester disease with cardiac involvement: Report of one case].
Topics: Aged; Anti-Inflammatory Agents; Cardiac Tamponade; Disease-Free Survival; Erdheim-Chester Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone; Sirolimus; Treatment Outcome | 2016 |
Sirolimus-induced lymphoedema.
Topics: Adult; Drug Substitution; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lower Extremity; Lymphedema; Lymphography; Male; Prednisone; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2016 |
Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Coculture Techniques; Cyclosporine; Cytokines; Dexamethasone; Female; Flow Cytometry; Glucocorticoids; Immunosuppressive Agents; Lymphocyte Activation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred BALB C; Mycophenolic Acid; Prednisone; Sirolimus; T-Lymphocyte Subsets | 2017 |
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
Topics: Antibodies, Monoclonal; Basiliximab; Drug Therapy, Combination; Female; Galactose; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recombinant Fusion Proteins; Sirolimus; Tacrolimus | 2016 |
A Retrospective Study on Mycophenolic Acid Drug Interactions: Effect of Prednisone, Sirolimus, and Tacrolimus With MPA.
Topics: Area Under Curve; Child; Child, Preschool; Drug Interactions; Drug Monitoring; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Sirolimus; Tacrolimus | 2017 |
Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy.
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Sirolimus; Skin Neoplasms; Treatment Outcome | 2018 |
Early Sirolimus-Based Immunosuppression is Safe for Lung Transplantation Patients: Retrospective, Single Arm, Exploratory Study.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Prednisone; Retrospective Studies; Sirolimus | 2018 |
The long-term effects of rapamycin-based immunosuppressive protocols on the expression of renal aquaporins 1, 2, 3 and 4 water channels in rats.
Topics: Animals; Aquaporins; Cyclosporine; Immunosuppressive Agents; Kidney; Mycophenolic Acid; Prednisone; Rats; Rats, Wistar; Sirolimus; Water | 2021 |
Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.
Topics: COVID-19; Cytokines; Humans; Immunity; Immunosuppression Therapy; Leukocytes, Mononuclear; Mycophenolic Acid; Prednisone; Sirolimus; Tacrolimus | 2021 |
Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
Topics: Animals; Autophagy; Beclin-1; Caspase 3; Chloroquine; Creatinine; Desmin; Doxorubicin; Eosine Yellowish-(YS); Hematoxylin; Lipopolysaccharides; Mammals; Mice; Microtubule-Associated Proteins; Nephrotic Syndrome; Periodic Acid; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Podocytes; Prednisone; Proto-Oncogene Proteins c-akt; Salvia miltiorrhiza; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Case report: Dynamic antibody monitoring in a case of anti-recombinant human erythropoietin-mediated pure red cell aplasia with prolonged course after kidney transplantation.
Topics: Antibodies; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Recombinant Proteins; Red-Cell Aplasia, Pure; Sirolimus | 2022 |
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis.
Topics: Fibrosis; Humans; Inflammation; Prednisone; Retroperitoneal Fibrosis; Sirolimus; TOR Serine-Threonine Kinases | 2023 |